Home Visit
Upload
.png)
NextGen BRCA Somatic, FFPE tissue in Ghaziabad
50+ booked in last 3 days
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
WIthin 25 Days
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Next-generation sequencing (NextGen) of BRCA somatic mutations in formalin-fixed paraffin-embedded (FFPE) tissue samples plays a pivotal role in identifying specific genetic alterations within the BRCA genes. This molecular analysis is particularly relevant in the context of PARP inhibitor therapy. PARP inhibitors are a class of targeted cancer treatments that show effectiveness in patients with BRCA mutations, as these mutations impair DNA repair mechanisms. By assessing somatic mutations in the BRCA genes using NextGen sequencing on FFPE tissue samples, healthcare providers can identify actionable genetic changes that inform the use of PARP inhibitor therapies. This personalized approach enhances treatment decisions and potentially improves outcomes for individuals with cancers linked to BRCA mutations.
Frequently Asked Questions
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
1707898101.webp)
WhatsApp